Related Experiment Videos
Differences in vascular response between primary and transplanted tumours.
S B Field1, S Needham, I A Burney
1MRC Cyclotron Unit, Hammersmith Hospital, London, UK.
British Journal of Cancer
|May 1, 1991
Summary
Tumour vascular response to hydralazine differs significantly between primary and transplanted tumors. Transplanted tumors show a much higher response rate, suggesting transplantation artifacts may influence tumor vascularity.
Area of Science:
- Oncology
- Vascular Biology
- Medical Imaging
Background:
- Most tumor vasculature studies use transplanted tumors in rodents.
- Primary and transplanted tumors may exhibit distinct vascular characteristics.
- Understanding these differences is crucial for accurate preclinical research.
Purpose of the Study:
- To investigate if the vascular response to hydralazine is consistent between primary tumors and tumors derived from them via transplantation.
- To determine the impact of tumor transplantation on vascular reactivity.
Main Methods:
- Induction of primary tumors in mice via local irradiation.
- Administration of hydralazine (5 mg kg-1, intraperitoneal) to assess vascular response.
- Monitoring metabolic changes indicative of perfusion using 31P Magnetic Resonance Spectroscopy (31P MRS).
- Histological comparison of primary and transplanted tumors.
Main Results:
- Only 36% (4/11) of primary tumors responded to hydralazine.
- Tumors derived from a non-responding primary tumor showed a significantly higher response rate of 94% (16/17).
- The difference in response rates between primary and transplanted tumors was statistically significant (P = 0.001).
Conclusions:
- Tumor transplantation significantly alters the vascular response to hydralazine compared to primary tumors.
- The observed discrepancy suggests that transplantation artifacts may be a primary driver of altered tumor vascularity.
- Further research is needed to elucidate the specific mechanisms underlying this transplantation-induced artifact.